Literature DB >> 23524960

Lymphatic vessels clean up your arteries.

Carlos Fernández-Hernando1.   

Abstract

Reverse cholesterol transport (RCT) is the pathway by which cholesterol accumulated in peripheral tissues, including the artery wall, is transported to the liver for excretion. There is strong evidence suggesting that interventions that increase macrophage cholesterol efflux and RCT would be antiatherogenic. In this issue of the JCI, Martel et al. investigate the contribution of lymphatic vasculature to RCT. Their results support the concept that the lymphatic vessel route is critical for RCT from atherosclerotic plaques. Therefore, strategies to improve lymphatic transport might be useful for treating atherosclerotic vascular disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23524960      PMCID: PMC3613935          DOI: 10.1172/JCI68657

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  21 in total

1.  Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo.

Authors:  Snehal U Naik; Xun Wang; Jaqueline S Da Silva; Michael Jaye; Colin H Macphee; Muredach P Reilly; Jeffrey T Billheimer; George H Rothblat; Daniel J Rader
Journal:  Circulation       Date:  2005-12-19       Impact factor: 29.690

2.  Synthetic LXR ligand inhibits the development of atherosclerosis in mice.

Authors:  Sean B Joseph; Elaine McKilligin; Liming Pei; Michael A Watson; Alan R Collins; Bryan A Laffitte; Mingyi Chen; Grace Noh; Joanne Goodman; Graham N Hagger; Jonathan Tran; Tim K Tippin; Xuping Wang; Aldons J Lusis; Willa A Hsueh; Ronald E Law; Jon L Collins; Timothy M Willson; Peter Tontonoz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

3.  Lymphatic vascular defects promoted by Prox1 haploinsufficiency cause adult-onset obesity.

Authors:  Natasha L Harvey; R Sathish Srinivasan; Miriam E Dillard; Nicole C Johnson; Marlys H Witte; Kelli Boyd; Mark W Sleeman; Guillermo Oliver
Journal:  Nat Genet       Date:  2005-09-18       Impact factor: 38.330

4.  MiR-33 contributes to the regulation of cholesterol homeostasis.

Authors:  Katey J Rayner; Yajaira Suárez; Alberto Dávalos; Saj Parathath; Michael L Fitzgerald; Norimasa Tamehiro; Edward A Fisher; Kathryn J Moore; Carlos Fernández-Hernando
Journal:  Science       Date:  2010-05-13       Impact factor: 47.728

5.  Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome.

Authors:  Gregory G Schwartz; Anders G Olsson; Christie M Ballantyne; Phillip J Barter; Ingar M Holme; David Kallend; Lawrence A Leiter; Eran Leitersdorf; John J V McMurray; Prediman K Shah; Jean-Claude Tardif; Bernard R Chaitman; Regina Duttlinger-Maddux; John Mathieson
Journal:  Am Heart J       Date:  2009-12       Impact factor: 4.749

6.  Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques.

Authors:  Jaime Llodrá; Véronique Angeli; Jianhua Liu; Eugene Trogan; Edward A Fisher; Gwendalyn J Randolph
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-27       Impact factor: 11.205

7.  Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo.

Authors:  Xun Wang; Heidi L Collins; Mollie Ranalletta; Ilia V Fuki; Jeffrey T Billheimer; George H Rothblat; Alan R Tall; Daniel J Rader
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

8.  The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis.

Authors:  Daniel J Rader; Eric T Alexander; Ginny L Weibel; Jeffrey Billheimer; George H Rothblat
Journal:  J Lipid Res       Date:  2008-12-08       Impact factor: 5.922

Review 9.  Intestinal lipid absorption.

Authors:  Jahangir Iqbal; M Mahmood Hussain
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-01-21       Impact factor: 4.310

10.  LXR agonist suppresses atherosclerotic lesion growth and promotes lesion regression in apoE*3Leiden mice: time course and mechanisms.

Authors:  Lars Verschuren; Jitske de Vries-van der Weij; Susanne Zadelaar; Robert Kleemann; Teake Kooistra
Journal:  J Lipid Res       Date:  2008-08-30       Impact factor: 5.922

View more
  4 in total

Review 1.  Novel Functions of Endothelial Scavenger Receptor Class B Type I.

Authors:  Liming Yu; Yao Dai; Chieko Mineo
Journal:  Curr Atheroscler Rep       Date:  2021-01-09       Impact factor: 5.967

Review 2.  Endothelial Transcytosis of Lipoproteins in Atherosclerosis.

Authors:  Xinbo Zhang; William C Sessa; Carlos Fernández-Hernando
Journal:  Front Cardiovasc Med       Date:  2018-09-25

Review 3.  Arterial Lymphatics in Atherosclerosis: Old Questions, New Insights, and Remaining Challenges.

Authors:  Gábor Csányi; Bhupesh Singla
Journal:  J Clin Med       Date:  2019-04-11       Impact factor: 4.241

Review 4.  Lymphatic Vessel Regression and Its Therapeutic Applications: Learning From Principles of Blood Vessel Regression.

Authors:  Faisal Masood; Rohan Bhattaram; Mark I Rosenblatt; Andrius Kazlauskas; Jin-Hong Chang; Dimitri T Azar
Journal:  Front Physiol       Date:  2022-03-22       Impact factor: 4.755

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.